A52 BUTYRATE SUPPLEMENTATION AMELIORATES DAMAGE CAUSED BY ENTERIC CITROBACTER RODENTIUM INFECTION

BACKGROUND: Patients with inflammatory bowel disease (IBD) often display a dysbiotic microbiome as well as a defective intestinal mucus layer, which appears thinner and more penetrable than the mucus layer of healthy subjects. Tributyrin (TB), a prodrug of butyric acid, has shown beneficial effects...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Can Assoc Gastroenterol
Asıl Yazarlar: Celiberto, L S, Healey, G, Xu, J, Xia, L, Vallance, B
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Poster of Distinction
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043417/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz047.051
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller